|
Q4 2021
Filed on Jan 14, 2022
|
150
|
$74.17 - $84.21
$11.1K - $12.6K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
120
|
$26.98 - $31.68
$3.24K - $3.8K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
357
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
4,056
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
100
|
$35.48 - $67.33
$3.55K - $6.73K
|
|
Tiziana Life Sciences PLC
|
Q4 2021
Filed on Jan 14, 2022
|
750
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
6,000
|
$4.27 - $6.97
$25.6K - $41.8K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
1,140
|
$4.6 - $7.41
$5.24K - $8.45K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
569
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
409
|
$14.7 - $28.67
$6.01K - $11.7K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
1,000
|
$2.53 - $3.51
$2.53K - $3.51K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
1,000
|
$12.84 - $16.7
$12.8K - $16.7K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
3,191
|
$0.7 - $1.94
$2.23K - $6.19K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
308
|
$61.54 - $80.75
$19K - $24.9K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
1,098
|
$4.68 - $5.99
$5.14K - $6.58K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
800
|
$4.89 - $10.7
$3.91K - $8.56K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
360
|
$6.7 - $13.55
$2.41K - $4.88K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
141
|
$7.83 - $19.23
$1.1K - $2.71K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
1,000
|
$3.09 - $7.46
$3.09K - $7.46K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
4,000
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
1,900
|
$4.99 - $7.46
$9.48K - $14.2K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
10,000
|
$0.69 - $1.73
$6.9K - $17.3K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
392
|
$14.48 - $35.73
$5.68K - $14K
|
|
Pieris Pharmaceuticals Inc
|
Q3 2021
Filed on Oct 22, 2021
|
5,000
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
8,020
|
N/A
|
|
First Eagle Senior Loan Fund
|
Q3 2021
Filed on Oct 22, 2021
|
1,800
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
200
|
$4.76 - $8.8
$952 - $1.76K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
7,000
|
$1.8 - $2.55
$12.6K - $17.9K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
1,450
|
$5.93 - $17.83
$8.6K - $25.9K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
167
|
$90.29 - $119.5
$15.1K - $20K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
1,400
|
$10.8 - $16.09
$15.1K - $22.5K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
680
|
$20.89 - $26.41
$14.2K - $18K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
360
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
300
|
$2.91 - $4.83
$873 - $1.45K
|
|
Reinvent Technology Partners
|
Q3 2021
Filed on Oct 22, 2021
|
1,000
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
1,972
|
$59.15 - $62.47
$117K - $123K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
1,000
|
$17.28 - $35.53
$17.3K - $35.5K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
2,411
|
$33.38 - $45.11
$80.5K - $109K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
15,000
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
22,600
|
$2.17 - $3.49
$49K - $78.9K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
2,618
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
43
|
$30.78 - $34.48
$1.32K - $1.48K
|
|
Churchill Capital Corp Iv
|
Q3 2021
Filed on Oct 22, 2021
|
700
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
641
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
74
|
$14.64 - $16.3
$1.08K - $1.21K
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
157
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
1,000
|
$11.18 - $11.88
$11.2K - $11.9K
|
|
Foley Trasimene Acquistn Cor
|
Q3 2021
Filed on Oct 22, 2021
|
1,050
|
N/A
|
|
|
Q3 2021
Filed on Oct 22, 2021
|
7,084
|
N/A
|
|
Blackrock 2022 Gbl Incm Opp
|
Q3 2021
Filed on Oct 22, 2021
|
770
|
N/A
|
|